CALCIUM GLUCONATE IN SODIUM CHLORIDE- calcium gluconate injection, solution Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

calcium gluconate in sodium chloride- calcium gluconate injection, solution

wg critical care, llc - calcium gluconate monohydrate (unii: czn0mi5r31) (calcium cation - unii:2m83c4r6zb) - calcium gluconate in sodium chloride injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. limitations of use the safety of calcium gluconate in sodium chloride injection for long term use has not been established. calcium gluconate in sodium chloride injection is contraindicated in: •hyperca lcemia • neonates (28 days of age or younger) receiving ceftriaxone [see warnings and precautions (5.2)] risk summary limited available data with calcium gluconate injection use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes. there are risks to the mother and the fetus associated with hypocalcemia in pregnancy [see clinical considerations] . the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respecti

CALCIUM GLUCONATE INJECTION, USP 10% SOLUTION Kanada - Englisch - Health Canada

calcium gluconate injection, usp 10% solution

fresenius kabi canada ltd - calcium gluconate - solution - 100mg - calcium gluconate 100mg - replacement preparations

CALCIUM GLUCONATE INJECTION, USP 10% SOLUTION Kanada - Englisch - Health Canada

calcium gluconate injection, usp 10% solution

baxter corporation - calcium gluconate - solution - 100mg - calcium gluconate 100mg

PHEBRA CALCIUM GLUCONATE 4.765g/50mL Injection vial Australien - Englisch - Department of Health (Therapeutic Goods Administration)

phebra calcium gluconate 4.765g/50ml injection vial

phebra pty ltd - calcium gluconate monohydrate, quantity: 95.3 mg/ml - injection, solution - excipient ingredients: calcium saccharate; water for injections - calcium gluconate is a calcium salt used primarily for the prevention and treatment of calcium deficiency. parenteral administation of calcium gluconate is needed in acute hypocalcaemia and hypocalcsemic tetany. it can be given intravenously in the treatment of severe hyper-kalaemia and in overdosage of magnesium sulphate, as calcium is the antagonist of magnesium toxicity. iv injections have been used in the treatment of acute renal biliary and intestinal colic. calcium has been used as an inotrope in cardiac resuscitation. they may also be used for the prevention of hypocalcaemia in exchange transfusions, and in long term electrolyte replacement therapy.

SYKES CALCIUM GLUCONATE 23%- calcium gluconate solution Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

sykes calcium gluconate 23%- calcium gluconate solution

sypharma pty ltd - calcium gluconate (unii: sqe6vb453k) (calcium cation - unii:2m83c4r6zb) - calcium gluconate 23 g in 100 ml - for use in cattle as an aid in treating uncomplicated milk fever (parturient paresis).

CALCIUM GLUCONATE injection, solution Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

calcium gluconate injection, solution

a-s medication solutions - calcium gluconate monohydrate (unii: czn0mi5r31) (calcium cation - unii:2m83c4r6zb) - calcium gluconate injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. limitations of use the safety of calcium gluconate injection for long term use has not been established. calcium gluconate injection is contraindicated in: - hypercalcemia - neonates (28 days of age or younger) receiving ceftriaxone [see warnings and precautions (5.2)] risk summary limited available data with calcium gluconate injection use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes. there are risks to the mother and the fetus associated with hypocalcemia in pregnancy [see clinical considerations] . the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. clinical considerations disease-associated maternal

DBL™ Calcium Gluconate Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

dbl™ calcium gluconate

pfizer new zealand limited - calcium gluconate monohydrate 100 mg/ml;   - solution for injection - 1000 mg/10ml - active: calcium gluconate monohydrate 100 mg/ml   excipient: calcium saccharate water for injection - parenteral administration of calcium gluconate is required in acute hypocalcaemia and hypocalcaemic tetany. it may be administered intravenously as an adjunct in the treatment of severe hyperkalaemia and as an aid in the treatment of depression due to overdose of magnesium sulphate (calcium is the antagonist of magnesium toxicity). intravenous injections of calcium have been used in the treatment of acute renal, biliary and intestinal colic. calcium has been used as an inotrope in cardiac resuscitation. calcium salts may also be used in the prevention of hypocalcaema in exchange transfusions and in long term electrolyte replacement therapy.

INDEPENDENTS OWN METAJECT CBG CALCIUM BOROGLUCONATE INJECTION Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

independents own metaject cbg calcium borogluconate injection

the hunter river company pty limited - calcium as calcium borogluconate - parenteral liquid/solution/suspension - calcium as calcium borogluconate mineral-calcium active 29.7 g/l - nutrition & metabolism